Corrigendum to "Therapeutic potential of dinitrobenzene sulfonic acid (DNBS)-induced colitis in mice by targeting IL-1 β and IL-18'' [Biochem. Pharmacol. 155 (2018) 150-161]

Biochem Pharmacol. 2024 Mar 2;222:116089. doi: 10.1016/j.bcp.2024.116089. Online ahead of print.NO ABSTRACTPMID:38432053 | DOI:10.1016/j.bcp.2024.116089
Source: Biochemical Pharmacology - Category: Drugs & Pharmacology Authors: Source Type: research